XNAS:GYRO Gyrodyne Company of America Quarterly Report 10-Q Filing - 6/30/2012

Effective Date 6/30/2012

XNAS:GYRO Fair Value Estimate
Premium
XNAS:GYRO Consider Buying
Premium
XNAS:GYRO Consider Selling
Premium
XNAS:GYRO Fair Value Uncertainty
Premium
XNAS:GYRO Economic Moat
Premium
XNAS:GYRO Stewardship
Premium
 
 
FORM 10-Q
 
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
(Mark One)
[X]          QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended                 June 30, 2012               

OR
 
[ ]            TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ____________ to ____________
 
Commission file number                0-1684               
 
Gyrodyne Company of America, Inc.
(Exact name of registrant as specified in its charter)
 
New York 11-1688021
(State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.)
 
1 Flowerfield, Suite 24, St. James, NY 11780
(Address and Zip Code of principal executive offices)
 
(631) 584-5400
(Registrant’s telephone number, including area code)
 

(Former name, former address and former fiscal year, if changed since last report)
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes X No ___

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes_X__   No___

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer  o                                                 Accelerated filer o
Non-accelerated filer     o                                                Smaller reporting company x
(Do not check if a smaller reporting company)

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes __  No X

On July 31, 2012, 1,482,680 shares of the Registrant’s common stock, par value $1.00 per share, were outstanding.
 
 
Seq. Page 1

 
 
INDEX TO QUARTERLY REPORT OF GYRODYNE COMPANY OF AMERICA, INC.
QUARTER ENDED JUNE 30, 2012



          
  Seq. Page
   
Form 10-Q Cover
1
   
Index to Form 10-Q
2
   
PART I - FINANCIAL INFORMATION
3
   
Item 1. Financial Statements.
3
   
Condensed Consolidated Balance Sheets as of June 30, 2012 (unaudited) and December 31, 2011
3
   
Condensed Consolidated Statements of Operations
4
   
Condensed Consolidated Statements of Comprehensive Income (Loss)
5
   
Condensed Consolidated Statements of Cash Flows
6
   
Notes to Condensed Consolidated Financial Statements
7
   
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
14
   
Item 3. Quantitative and Qualitative Disclosures About Market Risk.
22
   
Item 4. Controls and Procedures.
22
   
PART II - OTHER INFORMATION
22
   
Item 1. Legal Proceedings.
22
   
Item 6. Exhibits.
23
   
SIGNATURES
24
   
EXHIBIT INDEX
25
 
 
Seq. Page 2

 



PART I - FINANCIAL INFORMATION
Item 1. Financial Statements.
GYRODYNE COMPANY OF AMERICA, INC.
AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
 
ASSETS
 
June 30,
2012
   
December 31,
2011
 
 
 
(Unaudited)
       
REAL ESTATE
           
Rental property:
           
Land
  $ 5,163,093     $ 5,163,093  
Building and improvements
    33,006,932       32,855,932  
Machinery and equipment
    343,272       338,275  
      38,513,297       38,357,300  
Less accumulated depreciation
    5,828,782       5,381,026  
      32,684,515       32,976,274  
Land held for development:
               
Land
    558,466       558,466  
Land development costs
    1,662,794       1,607,600  
      2,221,260       2,166,066  
Total real estate, net
    34,905,775       35,142,340  
                 
Cash and cash equivalents
    4,293,940       10,375,994  
Investment in marketable securities
    5,195,698       -  
Rent receivable, net of allowance for doubtful accounts of $54,000 and $103,000, respectively
    119,398       83,942  
Deferred rent receivable
    186,872       137,220  
Condemnation proceeds receivable
    167,425,729       -  
Prepaid expenses and other assets
    1,184,211       1,002,250  
Prepaid pension costs
    1,067,154       1,064,843  
Total Assets
  $ 214,378,777     $ 47,806,589  
                 
LIABILITIES AND STOCKHOLDERS’ EQUITY
               
                 
LIABILITIES:
               
Accounts payable
  $ 340,357     $ 333,936  
Accrued liabilities
    437,993       456,166  
Deferred rent liability
    126,379       83,047  
Tenant security deposits payable
    444,910       486,861  
Mortgage loans payable
    20,837,797       21,143,780  
Deferred income taxes
    62,964,000       1,315,000  
Total Liabilities
    85,151,436       23,818,790  
                 
Commitments and contingencies
               
                 
STOCKHOLDERS’ EQUITY:
               
Common stock, $1 par value; authorized 4,000,000 shares; 1,723,888 shares issued; 1,482,680 shares outstanding
    1,723,888       1,723,888  
Additional paid-in capital
    17,747,069       17,747,069  
Accumulated other comprehensive income
    306,473       292,031  
Balance of undistributed income
    110,987,608       5,762,508  
      130,765,038       25,525,496  
Less cost of shares of common stock held in treasury; 241,208
    (1,537,697 )     (1,537,697 )
Total Stockholders’ Equity
    129,227,341       23,987,799  
Total Liabilities and Stockholders’ Equity
  $ 214,378,777     $ 47,806,589  
See notes to condensed consolidated financial statements
 
 
Seq. Page 3

 
 
GYRODYNE COMPANY OF AMERICA, INC.
AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(UNAUDITED)
 
   
Six Months Ended
June 30
   
Three Months Ended
June 30,
 
   
2012
   
2011
   
2012
   
2011
 
Revenues
                       
Rental income
  $ 2,288,428     $ 2,466,979     $ 1,101,161     $ 1,206,799  
Rental income - tenant reimbursements
    292,632       304,714       143,763       154,195  
Total
    2,581,060       2,771,693       1,244,924       1,360,994  
                                 
Expenses
                               
Rental expenses
    1,150,182       1,214,409       555,633       588,960  
General and administrative expenses
    952,262       907,729       477,429       452,178  
Depreciation
    447,756       408,810       223,323       204,205  
Total
    2,550,200       2,530,948       1,256,385       1,245,343  
                                 
Other Income (Expense):
                               
Interest income
    41,778       144       28,932       72  
Interest expense
    (513,017 )     (613,083 )     (252,105 )     (307,428 )
Total
    (471,239 )     (612,939 )     (223,173 )     (307,356 )
                                 
Net Loss before Condemnation Income and Provision for Income Taxes
    (440,379 )     (372,194 )     (234,634 )     (191,705 )
Income (expense) on condemnation
    100,048,691       (221,690 )     100,111,890       (53,024 )
Interest income on condemnation
    67,265,788       -       67,265,788       -  
                                 
Net Income (Loss) before Provision for Income Taxes
    166,874,100       (593,884 )     167,143,044       (244,729 )
Provision for Income Taxes
    61,649,000       -       61,649,000       -  
Net Income (Loss)
  $ 105,225,100     $ (593,884 )   $ 105,494,044     $ (244,729 )
                                 
 
                               
Net income (loss) per common share:
                               
Basic and diluted
  $ 70.97     $ (0.46 )   $ 71.15     $ (0.19 )
                                 
Weighted average number of common shares outstanding:
                               
Basic and diluted
    1,482,680       1,290,039       1,482,680       1,290,039  
 
See notes to condensed consolidated financial statements
 
 
Seq. Page 4

 

GYRODYNE COMPANY OF AMERICA, INC.
AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(UNAUDITED)
 
    Six Months Ended
June 30,
    Three Months Ended
June 30,
 
   
2012
   
2011
   
2012
   
2011
 
Net Income (loss)
  $ 105,225,100     $ (593,884 )   $ 105,494,044     $ (244,729 )
Other comprehensive income:
                               
Unrealized income on investments
    14,442       -       59,066       -  
Recognition of unrealized income on interest rate swap
    -       70,239       -       35,558  
Other comprehensive income
    14,442       70,239       59,066       35,558  
Comprehensive income (loss)
  $ 105,239,542     $ (523,645 )   $ 105,553,110     $ (209,171 )

See notes to condensed consolidated financial statements
 
 
Seq. Page 5

 
 
GYRODYNE COMPANY OF AMERICA, INC.
AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
 
   
Six Months Ended
June 30,
 
   
2012
   
2011
 
CASH FLOWS FROM OPERATING ACTIVITIES:
           
Net income (loss)
  $ 105,225,100     $ (593,884 )
Adjustments to reconcile net income (loss) to net cash used in operating activities:
               
Depreciation and amortization
    465,954       427,877  
Bad debt expense
    (48,511 )     12,000  
Net periodic pension benefit income
    (2,311 )     (20,694 )
Changes in operating assets and liabilities:
               
                 
Decrease (increase) in assets:
               
                 
Rent receivable
    13,055       59,653  
Deferred rent receivable
    (49,652 )     (19,537 )
Condemnation proceeds receivable
    (167,425,729 )     -  
Prepaid expenses and other assets
    (197,687 )     (78,660 )
Increase (decrease) in liabilities:
               
Accounts payable
    6,421       (273,282 )
Accrued liabilities
    (18,173 )     38,677  
Deferred rent liability
    43,332       78,357  
Tenant security deposits
    (41,952 )     13,439  
Deferred income taxes
    61,649,000       -  
Total adjustments
    (105,606,253 )     237,830  
Net cash used in operating activities
    (381,153 )     (356,054 )
                 
CASH FLOWS FROM INVESTING ACTIVITIES:
               
Purchase of building improvements and equipment
    (155,997 )     (456,501 )
Land development costs
    (55,194 )     (93,793 )
Purchases of marketable securities
    (5,366,421 )     -  
Principal repayments on investment in marketable securities
    185,165       -  
Net cash used in investing activities
    (5,392,447 )     (550,294 )
                 
CASH FLOWS FROM FINANCING ACTIVITIES:
               
Principal payments on mortgage loans payable
    (305,983 )     (282,022 )
Loan origination fees paid
    (2,471 )     -  
Net cash used in financing activities
    (308,454 )     (282,022 )
                 
Net decrease in cash and cash equivalents
    (6,082,054 )     (1,188,370 )
Cash and cash equivalents at beginning of period
    10,375,994       2,141,522  
Cash and cash equivalents at end of period
  $ 4,293,940     $ 953,152  
                 
Supplemental cash flow information:
               
Interest paid
  $ 518,317       604,513  

See notes to condensed consolidated financial statements
 
 
Seq. Page 6

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
 
1.   The Company:

Gyrodyne Company of America, Inc.  (“Gyrodyne” or the “Company”) is a self-managed and self-administered real estate investment trust (“REIT”) formed under the laws of the State of New York.  The Company manages its business as one segment.  The Company’s primary business is the investment in and the acquisition, ownership and management of a geographically diverse portfolio of medical office and industrial properties and development of industrial and residential properties, located in the Northeast and mid – Atlantic regions of the United States.  Substantially all of the Company’s rental properties are subject to net leases in which the tenant must reimburse Gyrodyne for a portion, all of or substantially all of the costs and/ or cost increases for utilities, insurance, repairs and maintenance, and real estate taxes.  Certain leases provide that the Company is responsible for certain operating costs.

As of June 30, 2012, the Company had 100% ownership in three medical office parks comprising an aggregate of approximately 131,000 rentable square feet and a multitenant industrial park comprising approximately 128,000 rentable square feet.  In addition, the Company has approximately 68 acres of property in St. James, New York, approximately 10 acres of which are utilized by the industrial park,  and an estimated 9.32% limited partnership interest in a limited partnership (the “Grove”) which owns an undeveloped Florida property (the “Grove Property”).

The Company has qualified, and expects to continue to qualify as a REIT under Section 856(c)(1) of the Internal Revenue Code of 1986 as amended (the “Code”).  Accordingly, the Company generally will not be subject to federal and state income tax, provided that we distribute at least 90% of our REIT taxable income, as defined under the Code, in the form of a dividend to our shareholders each year and comply with various other requirements.  As a result of the REIT Modernization Act of 1999, the Company is permitted to participate in certain activities without jeopardizing its REIT status which would have previously been precluded, provided the Company conducts these activities through an entity that elects to be treated as a taxable REIT subsidiary (“TRS”) under the Code.  The Company has one TRS, the only asset being its investment in the Grove, which will be subject to federal and state income tax on the income from these activities.
 
2.     Basis of Quarterly Presentations:

The accompanying quarterly financial statements have been prepared in conformity with accounting principles generally accepted in the United States (“GAAP”).  The financial statements of the Company included herein have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC” and, in the opinion of management, reflect all adjustments which are necessary to present fairly the results for the three and six-month periods ended June 30, 2012 and 2011.

Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations; however, management believes that the disclosures are adequate to make the information presented not misleading.

This report should be read in conjunction with the audited financial statements and footnotes therein included in the Annual Report on Form 10-K for the year ended December 31, 2011.

The results of operations for the three and six-month periods ended June 30, 2012 are not necessarily indicative of the results to be expected for the full year.

3.     Principles of Consolidation:

The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries.  All intercompany balances and transactions have been eliminated in consolidation.

4.     Investment in Marketable Securities
 
The Company determines the appropriate classification of securities at the time of purchase and reassesses the appropriateness of such classification at each reporting date. All marketable securities held by the Company have been classified as available-for-sale and, as a result, are stated at fair value, based on a pricing model that incorporates coupon type, prepayment speeds and the type of collateral backing the securities. Unrealized gains and losses on available-for-sale securities are recorded as a separate component of stockholders’ equity. Any realized gains and losses on the sale of securities, as determined on a first-in, first-out basis, will be included in the Consolidated Statements of Operations.
 
 
Seq. Page 7

 
 
The Company reviews its investments on a regular basis to evaluate whether or not each security has experienced an other-than-temporary decline in fair value. If it is believed that an other-than-temporary decline exists, the Company will write down the investment to market value and record the related write-down in the Consolidated Statements of Operations.
 
The historical cost and estimated fair value of investments in marketable securities available for sale as of June 30, 2012 are as follows:
 
   
Amortized
Cost
   
Gross
Unrealized
Gains
   
Fair
Value
 
Mortgage-backed Securities
  $ 5,181,256     $ 14,442     $ 5,195,698  
 
The Company’s investment is in conforming agency fixed rate mortgage pass through securities (“mortgage-backed securities”), each of which contained both AA and AAA ratings, the principal of which is fully guaranteed by agencies of the U.S. Government.  At June 30, 2012, marketable securities based on amortized cost, reflect a yield of approximately 2% and an adjusted duration of less than four years. The Company did not have any investments in mortgage-backed securities during the year ended December 31, 2011. The fair value of mortgage-backed securities was estimated based on a Level 2 methodology, additional details of which are discussed further in Note 11 – Fair Value of Financial Instruments.  None of the securities with an unrealized loss at June 30, 2012 are considered to be other-than-temporarily impaired, therefore the unrealized loss was reported in the Condensed Consolidated Statement of Comprehensive Income (Loss).    

5.      Earnings per Share:
 
Basic earnings per common share are computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period.  Diluted earnings per share give effect to stock options and warrants which are considered to be dilutive common stock equivalents.  The Company does not have outstanding dilutive common stock equivalents during the periods presented.  As a result, the basic and diluted earnings per share is the same.  Treasury shares have been excluded from the weighted average number of shares. The Company does not have any outstanding Common Stock equivalents as of June 30, 2012.

During the third quarter ended September 30, 2011, the Company filed a registration statement on Form S-3 with the Securities and Exchange Commission to register a number of shares of the Company’s common stock to be offered in a rights offering by the Company to its shareholders.   The rights offering resulted in 192,641 common shares being issued.

6.      Income Taxes:

The Company files a consolidated U.S. Federal Tax Return that includes all 100% owned subsidiaries.  State tax returns are filed on a consolidated or separate basis depending on the applicable laws.

Deferred income tax assets and liabilities are determined based on differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse.
 
The Condemnation litigation with the State of New York concluded in June and the State remitted payment in early July.
 
The following table provides the breakdown of the condemnation proceeds earned through June 30th, 2012:
 
   
Condemnation
   
Income Tax
 
   
Gross Proceeds
   
Provision
 
Gross gain from condemnation
  $ 98,685,000     $ 61,649,000  
Interest income on condemnation
    67,265,788       -  
Reimbursement of condemnation expenses
    1,474,941       -  
Total
  $ 167,425,729     $ 61,649,000  
 
In accordance with Section 1033 of the Internal Revenue Code, the Company has deferred recognition of the gain on the condemnation of its real property for income tax purposes.  If the Company replaces the condemned property with like kind property by April 30, 2013 (or such extended period approved by the Internal Revenue Service at its discretion), recognition of the gain is deferred until the newly acquired property is disposed of.  Pending a replacement property acquisition, the Company has recorded a provision for income taxes of $61,649,000 related to the condemnation award.  The provision for income taxes is directly related to the gain on condemnation of its real property and would reverse upon the purchase of like kind property.
 
 
Seq. Page 8

 
 
The Company converted to a REIT in 2007, effective April 1, 2006.  As long as Gyrodyne qualifies for REIT status and meets the like kind exchange and holding period requirements under Section 1033, the Company generally will not be subject to New York State and Federal corporate income taxes on income and gain generated and distributed after May 1, 2006.  REIT organizations are required to distribute a minimum of 90% of Net Income.  As a result, the Company has a contingent liability of approximately $25 million associated with the net income excluding the real estate gain, which is not a probable liability due to the Company’s intent to meet the REIT distribution requirements and is not reflected in the June 30, 2012 financial statements.
 
7.     Mortgage loans Payable:

Mortgage loans payable are comprised of the following:

 
 
June 30,
2012
   
December 31,
2011
   
 
 
(Unaudited)
       
Mortgage payable - Port Jefferson Professional Park (a)
  $ 5,063,767     $ 5,130,831  
Mortgage payable - Cortlandt Medical Center (b)
    4,427,500       4,532,500  
Mortgage payable - Fairfax Medical Center (c)
    7,515,969       7,598,188  
Mortgage payable - Flowerfield Industrial Park (d)
    3,830,561       3,882,261  
Total
  $ 20,837,797     $ 21,143,780  

(a) In June 2007, in connection with the purchase of the Port Jefferson Professional Park, the Company assumed a $5,551,191 mortgage payable to a bank (the “Port Jefferson Mortgage”). The Port Jefferson Mortgage bore interest at 5.75% through February 1, 2012.  Effective January 17th, 2012, the Company negotiated an interest rate modification from 5.75% to 5% for the 5 year period February 1, 2012 through February 1, 2017 and adjusts to the higher of 5.75% or 275 basis points in excess of the Federal Home Loan Bank’s five year Fixed Rate Advance (“Fixed Rate Advance”) thereafter.  The Port Jefferson Mortgage is payable in monthly installments of principal and interest totaling $33,439 through February 2012. From March 1, 2012 through February 1, 2022, the minimum monthly installment will be no less than $31,086 and will vary based upon the Fixed Rate Advance. In February 2022, a balloon payment is due of approximately $3,560,000. The Port Jefferson Mortgage is collateralized by the Port Jefferson Professional Park in Port Jefferson Station, New York.

(b) In June 2008, in connection with the purchase of the Cortlandt Medical Center in Cortlandt Manor, New York, the Company borrowed $5,250,000 from a bank (the “Cortlandt Mortgage”). The Cortlandt Mortgage originally bore interest at a per annum rate of 225 basis points above the one month LIBOR rate (4.71% at inception) through July 1, 2018, subject to monthly adjustment. The Cortlandt Mortgage is payable in monthly installments with a fixed principal payment of $17,500 plus interest, through June 1, 2018. In July 2018, a balloon payment is due of approximately $3,168,000. The Cortlandt Mortgage is collateralized by the Cortlandt Medical Center. As part of the terms and conditions of the Cortlandt Mortgage, reacting to an increase in the LIBOR rate, the Company exercised an option to enter into an interest rate swap agreement in November 2008 with the bank holding the mortgage, thereby fixing the interest rate at 5.66% through November 1, 2011. Following the expiration of the Interest Rate Swap Agreement, the Cortlandt Mortgage interest rate is variable and floating based on the one month Libor rate plus 225 basis points, which equates to approximately 2.5% at June 30, 2012, and December 31, 2011, respectively.  The Company continues to have an option to enter into an interest rate swap agreement but does not plan to hedge any variable interest rate risk for 2012.

(c) In March 2009, in connection with the purchase of the Fairfax Medical Center in Fairfax, Virginia by Virginia Healthcare Center, LLC (“VHC”), a wholly-owned subsidiary of the Company, VHC borrowed $8,000,000 from a bank (the “Fairfax Mortgage”). The Fairfax Mortgage bears interest at 5.875% through April 10, 2014 and thereafter adjusts to the higher of 5.50% or 300 basis points over the weekly average yield on five-year United States Treasury securities. The Fairfax Mortgage is collateralized by a Deed of Trust and Security Agreement establishing a first trust lien upon the land, buildings and improvements as well as a Collateral Assignment of Leases and Rents and matures on April 10, 2019. In April 2019, a balloon payment is due of approximately $6,120,000.  The payment of the indebtedness evidenced by the Fairfax Mortgage and the performance by VHC of its obligations thereunder have been guaranteed by the Company.

(d) On December 29, 2010, the Company closed on a mortgage loan with a bank for $4,000,000.  A portion of the proceeds was used to retire the outstanding line of credit with the Company’s previous lender of $1,750,000.  The mortgage loan has a maturity date of January 2, 2031 and a floating interest rate of prime plus 100 basis points with a  floor of 5%, to be adjusted once annually on its anniversary date.  The interest rate is 5% at June 30, 2012.  The mortgage loan is subject to a 20 year amortization schedule requiring monthly payments of principal and interest due on the first of each month beginning February 1, 2011. The mortgage loan is secured by approximately 35.1 acres of the Flowerfield Industrial Park including the respective buildings and related leases.  In the event of collection from New York State under the State of New York Court of Claims ruling on the Company’s condemnation case (Index No. 112279), the lender may require the Company to repay all or a part of the balance outstanding.  In early July, following the receipt of the condemnation proceeds, the lender communicated that it will not exercise its option to require the Company to repay a portion or all of the loan other than under its regularly scheduled amortization terms.
 
 
Seq. Page 9

 

8.     Retirement Plans:
The Company sponsors a Defined Benefit Retirement Plan for substantially all of its employees and records net periodic pension benefit / cost pro rata throughout the year.  The following table provides the components of net periodic pension benefit cost for the plan for the three and six-months ended June 30, 2012 and 2011 including the required and expected contributions:
 
    Six Months Ended
June 30
    Three Months Ended
June 30
 
    2012     2011     2012     2011  
Pension Benefits
                       
Service Cost
  $ 91,423     $ 63,948     $ 45,712     $ 31,974  
Interest Cost
    90,086       78,446       45,043       39,223  
Expected Return on Plan Assets
    (193,028 )     (162,486 )     (96,514 )     (81,243 )
Amortization of prior service costs
    11,288       -       5,644       -  
Amortization of Actuarial Loss
    (2,080 )     (602 )     (1,040 )     (301 )
Net Periodic Pension Benefit (Income) Cost After Curtailments and Settlements
  $ (2,311 )   $ (20,694 )   $ (1,155 )   $ (10,347 )
Minimum required contribution
  $ -     $ -     $ -     $ -  
Expected contribution
  $ -     $ -     $ -     $ -  

During the three and six-months ended June 30, 2012, the Company did not make any contribution to the plan.  The Company does not have a minimum required contribution for the December 31, 2012 plan year, and is not expecting to make a contribution for the related plan year.

9.     Commitments and Contingencies:

Lease revenue commitments - The approximate future minimum revenues from rental property under the terms of all noncancellable tenant leases, assuming no new or renegotiated leases are executed for such premises, are as follows:

Twelve  Months Ending June 30,
 
Amount
 
       
2013
  $ 3,679,000  
2014
    2,699,000  
2015
    2,013,000  
2016
    1,605,000  
2017
    1,225,000  
Thereafter
    2,626,000  
    $ 13,847,000  

Other commitments and contingencies As of June 30, 2012, other commitments and contingencies are summarized in the below table:

 Employment agreement with severance commitment contingencies
  $ 123,000  

Employment agreements - The Company has a compensation arrangement with its Chief Financial Officer.
 
 
Seq. Page 10

 

10.  Recent Accounting Pronouncements:

In May 2011, the FASB issued ASU 2011-04, “Fair Value Measurement (Topic 820), Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRS”.  The amendment results in a consistent definition of fair value and ensures the fair value measurement and disclosure requirements are similar between GAAP and International Financial Reporting Standards (“IFRS”). This amendment changes certain fair value measurement principles and enhances the disclosure requirements particularly for Level 3 fair value measurements. This amendment is effective for the Company on January 1, 2012. The adoption did not have a material effect on the Company’s consolidated financial position or results of operations.
 
In June 2011, the Financial Accounting Standards Board (“FASB”) issued ASU 2011-05, “Comprehensive Income (Topic 220), Presentation of Comprehensive Income”.  ASU 2011-05 amends the presentation of other comprehensive income and the Statement of Consolidated Operations. Under this amendment, entities will be required to present the total of comprehensive income, the components of net income,  and the components of other comprehensive income either in a single continuous statement of comprehensive income or in two separate but consecutive statements. Regardless of which reporting option is selected, the Company is required to present on the face of the financial statements, reclassification adjustments for items that are reclassified from other comprehensive income to net income in the statements where the components of net income and the components of other comprehensive income are presented.   The current option to report other comprehensive income and its components in the statement of changes in equity has been eliminated. This amendment is effective for the Company on January 1, 2012 and full retrospective application is required. The amendment did not have a material impact on its financial statements.
 
Affecting certain sections covered under ASU 2011-05,  in December, 2011, the FASB issued ASU 2011-12, “Comprehensive Income (Topic 220)”, Deferral of the Effective Date for Amendments to the Presentation of Reclassifications of Items out of Accumulated Other Comprehensive Income in ASU 2011-05”.  The pronouncement is effective for fiscal years and interim periods beginning January 1, 2012 with retrospective application for all comparative periods presented.  The Company’s adoption of the new standard did not have a material effect on the Company’s consolidated financial position or results of operations.

In September 2011, the Financial Accounting Standards Board (“FASB”) issued ASU 2011-08, “Intangibles – Goodwill and Other (Topic 350), Testing Goodwill for Impairment”.  ASU 2011-08 amends the required annual impairment testing of goodwill by providing an entity an option to first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount.  If, after assessing the totality of events and circumstances, an entity determines it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, then performing the two-step impairment test under Topic 350-24 and Topic 350-20-35-9 is unnecessary.  However, if an entity concludes otherwise, then it is required to perform the impairment testing under Topic 350-24 by calculating the fair value of the reporting unit and comparing the results with the carrying amount.  If the fair value exceeds the carrying amount, then the entity must perform the second step test of measuring the amount of the impairment test under Topic 350-20-35-9.  An entity has the option to bypass the qualitative assessment and proceed directly to the two step goodwill impairment test.  Additionally, the entity has the option to resume with the qualitative testing in any subsequent period.  The amendment is effective for the Company on January 1, 2012. The adoption did not have a material effect on the Company’s consolidated financial position or results of operations.
 
In December 2011, the FASB issued ASU 2011-11, “Balance Sheet (Topic 210), Disclosures about Offsetting Assets and Liabilities”.  The guidance in this update requires the Company to disclose information about offsetting and related arrangements to enable users of its financial statements to understand the effect of those arrangements on its financial position.  The pronouncement is effective for fiscal years and interim periods beginning on or after January 1, 2013 with retrospective application for all comparative periods presented.  The Company’s adoption of the new standard is not expected to have a material effect on the Company’s consolidated financial position or results of operations.

In July, 2012, the FASB issued ASU 2012-02, “Intangibles – Goodwill and Other (Topic).  ASU 2012-02 amends the required annual impairment testing of indefinite-lived intangible assets by providing an entity an option to first assess qualitative factors to determine whether it is more likely than not that the fair value of the indefinite-lived asset is less than its carrying amount.  If, after assessing the totality of events and circumstances, an entity determines it is not more likely than not that the fair value of the indefinite-lived asset is less than its carrying amount, then performing the two-step impairment test under Topic 350-30 is unnecessary.  However, if an entity concludes otherwise, then it is required to perform the impairment testing under Topic 350-30-35-18F by calculating the fair value of the reporting unit and comparing the results with the carrying amount.  If the fair value exceeds the carrying amount, then the entity must perform the second step test of measuring the amount of the impairment test under Topic 350-30-35-19.  An entity has the option to bypass the qualitative assessment and proceed directly to the two step goodwill impairment test.  Additionally, the entity has the option to resume with the qualitative testing in any subsequent period.  The pronouncement is effective for annual and interim impairment tests performed for fiscal years beginning after September 15, 2012 and early adoption is permitted.  The Company’s adoption of the new standard is not expected to have a material effect on the Company’s consolidated financial position or results of operations.
 
 
Seq. Page 11

 
 
11.   Fair Value of Financial Instruments:

Assets and Liabilities Measured at Fair-Value – The Company follows authoritative guidance on fair value measurements, which defines fair-value, establishes a framework for measuring fair-value, and expands disclosures about fair-value measurements. The guidance applies to reported balances that are required or permitted to be measured at fair-value under existing accounting pronouncements.
 
The Company follows authoritative guidance on the fair value option for financial assets, which permits companies to choose to measure certain financial instruments and other items at fair-value in order to mitigate volatility in reported earnings caused by measuring related assets and liabilities differently. However, we have not elected to measure any additional financial instruments and other items at fair-value (other than those previously required under other GAAP rules or standards) under the provisions of this standard.

The guidance emphasizes that fair-value is a market-based measurement, not an entity-specific measurement. Therefore, a fair-value measurement should be determined based on the assumptions that market participants would use in pricing the asset or liability. As a basis for considering market participant assumptions in fair-value measurements, the guidance establishes a fair-value hierarchy that distinguishes between market participant assumptions based on market data obtained from sources independent of the reporting entity (observable inputs that are classified within Levels 1 and 2 of the hierarchy) and the reporting entity’s own assumptions about market participant assumptions (unobservable inputs classified within Level 3 of the hierarchy). In instances where the determination of the fair-value measurement is based on inputs from different levels of the fair-value hierarchy, the level in the fair-value hierarchy within which the entire fair-value measurement falls is based on the lowest level input that is significant to the fair-value measurement in its entirety. Our assessment of the significance of a particular input to the fair-value measurement in its entirety requires judgment, and considers factors specific to the asset or liability.

The following table represents the carrying value and fair value of the Company’s financial assets and liabilities as of June 30, 2012 and December 31, 2011, respectively.

 
June 30, 2012
December 31, 2011
Description
Carrying Value
Fair Value
(Level 2)
Carrying Value
Fair Value
(Level 2)
Investment in Marketable Securities
$  5,195,698
$  5,195,698
N/A
           N/A

During 2012, the Company invested in mortgage backed securities with both AA and AAA ratings fully guaranteed by US government agencies (the Federal National Mortgage Association and the Federal Home Loan Mortgage Corporation).  The fair values of mortgage backed securities originated by US government agencies are based on a pricing model that incorporates coupon type, prepayment speeds and the type of collateral backing the securities.  A discount rate is applied to the cashflows in the model to arrive at the fair value.  Market quotes, current yields, and their spreads to benchmark indices are obtained for each type of security.  With this data, a yield curve is derived for each category of mortgage backed securities.  Each security is priced by discounting the cashflow stream by the appropriate yield found on the yield curve.  As the significant inputs used to derive the value of the mortgage-backed securities are observable market inputs, the fair value of these securities are included in the Level 2 fair value hierarchy.

The Company estimates that fair value approximates carrying value for cash equivalents, rents receivable, condemnation proceeds receivable, prepaid and other assets, and accounts payable due to the relatively short maturity of the instruments.

The Company determined the fair value of its mortgage loans payable approximates book value.  The Company based its decision by looking at current rates available based on the Company’s estimate for nonperformance and liquidity risk, the Company’s loan to value ratio, the maturity of the debt and the underlying security for the debt.
 
 
Seq. Page 12

 

The Grove investment is a distressed asset operating in a distressed environment where an orderly transaction is not available.  The Grove’s lender, Prudential Industrial Properties, LLC (“Prudential”), commenced a foreclosure action against the Grove by filing a complaint in the Circuit Court of Palm Beach County to foreclose upon the Grove Property, alleging that the Grove has defaulted on its loan from Prudential and that the Grove is indebted to Prudential in the amount of over $37 million in principal and over $8 million in interest and fees.  The facts and circumstances of the Grove make it unreasonable to present a fair value utilizing a Level 3 methodology, the lowest methodology which allows for broad assumptions; therefore, in accordance with the exception rules for thinly traded/lack of marketability of distressed assets, the Company is not presenting a fair value. The Company is accounting for the investment under the equity method. As of June 30, 2012, the carrying value of the Company’s investment was $0.

12.   Risk Management – Use of Derivative Instruments:

The Company entered into the Interest Rate Swap (“Swap”) agreement on the mortgage of the Cortlandt Medical Center in November 2008, fixing the interest rate at 5.66% through November 1, 2011.

The Swap was considered a derivative instrument.  The Company utilized the Swap agreement to minimize its interest rate exposure on the Cortlandt Medical Center mortgage.  The principal objective of this agreement was to limit the risks and/or costs associated with the Company’s operating structure as well as to hedge the specific transaction.  The Company had only one interest rate swap agreement with the purpose of hedging against a rise in LIBOR on the mortgage for the Cortlandt Medical Center.  The counterparty to the arrangement was the bank which holds the mortgage for the Cortlandt Medical Center.  The Company was potentially exposed to credit losses in the event of non-performance by the counterparty.  However, the Company did not expect the counterparty to fail to meet its obligations due to the same party holding both the Mortgage and the Swap Agreement.  The Company did not hedge credit or property value market risks through derivative financial instruments.

The Company formally assessed both at inception of the hedge, and on an ongoing basis, whether such derivatives are highly-effective in offsetting changes in cash flows of the hedged item.  If management determined that a derivative is not highly-effective as a hedge, or if a derivative ceases to be a highly-effective hedge, the Company would discontinue hedge accounting prospectively.  The related ineffectiveness would be charged to the Statement of Operations.

The valuation of these instruments was determined utilizing widely accepted valuation techniques including discounted cash flow analysis on the expected cash flows for the derivative.  This analysis includes the contractual terms of the derivative through the maturity date, and utilizes observable market based inputs including interest rate curves and implied volatilities.  The fair value of the interest rate swap was based on market standard methodology of netting the discounted future inflows and outflows.

Following the expiration of the Interest Rate Swap Agreement, the Company’s interest rate adjusted to 2.5% (225 basis points above the one month Libor rate (.25 % on June 30, 2012 and December 31, 2011 ).  As part of the terms and conditions of the Cortlandt Mortgage, the Company has the option to enter into a new Interest Rate Swap Agreement throughout the term of the loan.  Based on the current economic environment the Company has not entered into a new Interest Rate Swap Agreement.

13.  Accumulated Other Comprehensive Income (Loss):
 
Accumulated other comprehensive income as of June 30, 2012 and December 31, 2011 was $306,473 and $292,031, respectively. The balances were comprised of the following:
 
   
June 30, 2012
   
December 31, 2011
 
Unrecorded gain on investments
  $ 14,442     $ -  
Unrecorded income on pension
    292,031       292,031  
Accumulated other comprehensive income
  $ 306,473     $ 292,031  

14.  Condemnation:

On July 3, 2012, the Company received $167,501,657 from the State of New York (the “State”) in payment of the judgments in the Company’s favor in the condemnation litigation with the State.  The amount received consisted of $98,685,000 in additional damages, $1,474,941 in costs, disbursements and expenses, and $67,341,716 in interest.

The $167.5 million payment brings to a resolution the Company’s case for just compensation, commenced in 2006 for the 245.5 acres of its Flowerfield property in St. James and Stony Brook, New York (the “Property”) taken by the State.  The State had paid the Company $26,315,000 for the Property in March 2006, which the Company elected, under New York’s eminent domain law, to treat as an advance payment while it pursued its claim for just compensation.  The Court of Claims ruled in the Company’s favor in June 2010 when it awarded the Company $125,000,000, thereby requiring the State to pay an additional $98,685,000 plus statutory interest of nine percent from the date of taking on November 2, 2005 to the date of payment.  That judgment, as well as a related judgment for costs, disbursements and expenses, was affirmed by the Appellate Division and the Court of Appeals.
 
 
Seq. Page 13

 
 
The original advance payment of $26,315,000 was successfully reinvested in like-kind property under Section 1033 of the Internal Revenue Code , thereby deferring income tax on the related gain.  In accordance with Section 1033, the Company has deferred recognition of the gain on the condemnation of its real property for income tax purposes.  If the Company replaces the condemned property with like kind property by April 30, 2013 (or such extended period if requested and approved by the Internal Revenue Service at its discretion), recognition of the gain is deferred until the newly acquired property is disposed of.

15.  Reclassifications:

Certain amounts in the prior period have been reclassified to conform to the classification used in the current period.

Item 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operations.

When we use the terms “Gyrodyne,” the “Company,” “we,” “us,” and “our,” we mean Gyrodyne Company of America, Inc. and all entities owned by us, including non-consolidated entities, except where it is clear that the term means only the parent company.  References herein to our Quarterly Report are to this Quarterly Report on Form 10-Q for the three and six-months ended June 30, 2012.

Forward Looking Statements.  The statements made in this Form 10-Q that are not current or historical facts contain “forward-looking information” within the meaning of the Private Securities Litigation Reform Act of 1995, and Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, both as amended, which can be identified by the use of forward-looking terminology such as “may,” “will,” “anticipates,” “expects,” “projects,” “estimates,” “believes,” “seeks,” “could,” “should,” or “continue,” the negative thereof, other variations or comparable terminology.  Important factors, including certain risks and uncertainties, with respect to such forward-looking statements that could cause actual results to differ materially from those reflected in such forward-looking statements include, but are not limited to, risks and uncertainties relating to the process of exploring strategic alternatives, as well as statements regarding the evaluation of strategic alternatives, the effect of economic and business conditions, including risks inherent in the real estate markets of Suffolk and Westchester Counties in New York, Palm Beach County in Florida and Fairfax County in Virginia, risks and uncertainties relating to Gyrodyne’s undeveloped property in St. James, New York, and other risks detailed from time to time in the Company’s SEC reports. These and other matters the Company discusses in this Quarterly Report, or in the documents it incorporates by reference into this Quarterly Report, may cause actual results to differ from those the Company describes. The Company assumes no obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise.

Overview:

General:  We are a self-managed and self-administered real estate investment trust formed under the laws of the State of New York.  We operate primarily in one segment.  The Company’s primary business is the investment in and the acquisition, ownership and management of a geographically diverse portfolio of medical office and industrial properties and development of industrial and residential properties.  Substantially all of our rental properties are subject to net leases in which the tenant must reimburse Gyrodyne for a portion of or all or substantially all of the costs and /or cost increases for utilities, insurance, repairs and maintenance, and real estate taxes.

As of June 30, 2012 the Company had 100% ownership, directly or indirectly, in three medical office parks, comprising an aggregate of approximately 131,000 rentable square feet and a multitenant industrial park comprising approximately 128,000 rentable square feet.  In addition, the Company has approximately 68 acres of property located in St. James, New York, approximately 10 of which are utilized by the industrial park and the balance remains undeveloped.  Furthermore, the Company has an estimated 9.32% limited partnership in a limited partnership which owns an undeveloped Florida property called “the Grove Property”.

With the exception of the receipt of the condemnation proceeds, our revenues and cash flows are generated predominantly from property rent receipts.  Growth in revenues and cash flows has been and remains directly correlated to our ability to (1) re-lease suites that are vacant or may become vacant at favorable rates, (2) successfully complete the liquidity events in our strategic plan and / or the reinvestment under Section 1033 of the condemnation proceeds.
 
 
Seq. Page 14

 

Our properties are concentrated in New York State and Northern Virginia. We compete with a large number of real estate property owners and developers, some of which may be willing to accept lower returns on their investments. The principal factors of competition are rents charged, attractiveness of location, the quality of the property and breadth and quality of services provided. Our success depends upon, among other factors, trends of the national, regional and local economies, financial condition and operating results of current and prospective tenants and customers, availability and cost of capital, construction and renovation costs, taxes, governmental regulations, legislation and population trends.  See “Part I” in our Annual Report on Form 10-K for the year ended December 31, 2011 for additional information regarding these factors.
 
The economic recession and illiquidity and volatility in the financial and capital markets from 2008 to present has continued to  negatively affect substantially all businesses, including ours.  Although signs of an economic recovery beginning in 2010 through early 2012 have emerged, it is not possible for us to quantify the timing and impact of the recovery on our future financial results.  The length and depth of the economic recession combined with the slow economic recovery, has continued to negatively impact the real estate industry. Additionally, the Company stated in its 2010 through 2012 periodic filings that it believes the full impact of the economic downturn has not yet been fully absorbed by the real estate market, partially attributable to the Company’s belief that lease commitments, by their very nature, expire over time resulting in the vacancy impact of an economic slowdown occurring over a similar period of time as tenants cannot reduce their space demands until their leases expire.  The continuation of negative absorption rates into the first quarter in many regions across the country, including Long Island, continues to confirm the negative impact.

Global Credit and Financial Crisis:  The continued concerns about the impact of a widespread and long term global credit and financial crisis have contributed to market volatility and diminishing expectations for the real estate industry, including the potential downward pressure on our common stock price.  As a result, our business continues to be impacted by factors including (1) increased challenges in re-leasing space, and (2) potential risks stemming from late rental receipts, tenant defaults and tenant bankruptcies.

Health Care Legislation:  The Federal health care legislation enacted in 2010 will potentially affect medical office real estate due to the direct impact on its tenant base.  While the impact is not expected to be immediate due to the multi-year phase in period of the legislation, medical professionals are reviewing their real estate options which include remaining status quo, increasing tenant space to address a higher volume of patients as well as combining practices with other professionals.  As a result, our business could be impacted by factors including (1) difficulty transitioning doctors to longer term leases, (2) difficulty raising rates and (3) increased challenges in re-leasing space.

As of June 30, 2012, the average effective rental revenue per square foot adjusted for tenant improvements was $20.19 compared to $20.22 on December 31, 2011.  The Company defines the effective revenue per square foot as the annual rate per square foot stated in the lease reduced by the average annual tenant improvement allowance provided for in such leases.

Business Strategy:  We have focused our business strategy to strike a balance between preserving capital and improving the market value of our portfolio to meet our long term goal of executing on a liquidity event or series of liquidity events.  Included within this strategy were, and except for the last item, continue to be our objectives:

 
·
actively managing our portfolio to improve our operating cash flow;

 
·
pursuing the re-zoning effort of the Flowerfield property to maximize its value;

 
·
limiting our use of capital to that which preserves the market value of our real estate portfolio;
 
 
·
maximizing our working capital without materially increasing our debt service requirements; and

 
·
diligently managing the condemnation lawsuit which was concluded June 5, 2012 with the related payment received in July 2012.
 
We believe these objectives strengthen our business and enhance its value.

Following the receipt of the condemnation proceeds in early July, the Board of Directors established a committee to manage the process of selecting legal and financial advisors to help the Company pursue strategic alternatives and make recommendations to the Board of Directors. In that regard, on August 10, 2012 the Company retained Skadden, Arps, Slate, Meagher & Flom, LLP.

Second Quarter 2012 Transaction Summary

The following summarizes our significant transactions and other activity during the three months ended June 30, 2012.
 
Investments – The Company received principal distributions during the second quarter of approximately $169,000 from its first quarter investment of $5.4 million in conforming agency fixed rate mortgage pass through securities with both AA and AAA ratings fully guaranteed by US government agencies (the Federal National Mortgage Association and the Federal Home Loan Mortgage Corporation).  The portfolio is currently generating a yield of approximately 2%.
 
 
Seq. Page 15

 

Leasing – During the three months ended June 30, 2012, the Company executed 10 lease renewals encompassing approximately 20,000 square feet, and approximately $314,000 in annual revenue.  In addition, the Company entered into 2 new leases encompassing approximately 3,000 square feet and $63,000 in annual revenue.  The increase in revenue from its new leases and contractual annual increases was offset by 4 lease terminations encompassing approximately 10,000 square feet and approximately $290,000 in annual revenue. The Company generated a decrease in net deferred revenue of approximately $11,000.

The new leases and lease extensions signed during the first quarter included tenant improvement allowances which the Company estimates at a cost of approximately $50,000, and no significant rent abatements.  There were no significant lease commissions paid by the Company during the second quarter.

The continued economic volatility for small businesses and medical practitioners have impacted property management firms, including the Company’s ability to renew leases at comparable rates if at all, without providing either rent abatements or comparable other lease incentives.  During 2011 through June 2012, medical office parks and industrial parks experienced degradation in both rental rates and occupancy.  Rental revenues were $1,101,161 and $1,187,267 for the three months ended June 30, 2012, and March 31, 2012, respectively, a quarter over quarter decrease of $86,106.  Although the Company successfully mitigated the decreased revenues during the quarter-ended March 31, 2012, limiting the reduction to $8,023 from the previous quarter, the degradation in revenue during the second quarter is a reflection of the continuing challenges to maintain both rental rates and occupancy during the slow economic recovery.

Re-tenanting vacant space, renewing tenants, and transitioning tenants to longer term leases has resulted in total lease commitments as of June 30, 2012 and March 31, 2012 of $13,847,000 and $13,316,000, respectively, an increase of $531,000.  During the second quarter the Company did not offer significant tenant improvements to attract new tenants.  However, if the challenges on reletting space continues, the Company may offer tenant improvements in exchange for signing long term lease commitments.

Condemnation lawsuit – On July 3, 2012, the Company received $167,501,656.95 from the State of New York (the “State”) in payment of the Judgments in the Company’s favor in the condemnation litigation with the State.  The amount received consisted of $98,685,000 in additional damages, $1,474,940.67 in costs, disbursements and expenses, and $67,341,716.28 in interest.

The $167.5 million payment brings to a successful resolution the Company’s case for just compensation, commenced in 2006 for the 245.5 acres of its Flowerfield property in St. James and Stony Brook, New York (the “Property”) taken by the State.  The State had paid the Company $26,315,000 for the Property at the time of the taking, which the Company elected, under New York’s eminent domain law, to treat as an advance payment while it pursued its claim for just compensation.  The Court of Claims ruled in the Company’s favor in June 2010 when it awarded the Company $125,000,000, thereby requiring the State to pay an additional $98,685,000 plus statutory interest of nine percent from the date of taking on November 2, 2005 to the date of payment.  That Judgment, as well as a related Judgment for costs, disbursements and expenses, was affirmed by the Appellate Division and the Court of Appeals.

The Company recorded the income of $167,425,729 less condemnation costs incurred in its financial statements for the quarter ended June 30, 2012, including the interest through June 30, 2012.  As a result of the payment being received in early July, the interest of $104,928 for the first three days in July will be reflected in the financial statements for the third quarter ending September 30, 2012.

The Grove

On March 18, 2011, the Grove’s lender, Prudential Industrial Properties, LLC (“Prudential”), commenced a foreclosure action against the Grove by filing a complaint in the Circuit Court of Palm Beach County to foreclose upon the Grove Property, alleging that the Grove has defaulted on its loan from Prudential and that the Grove is indebted to Prudential in the amount of over $37 million in principal and over $8 million in interest and fees.  The Grove continues to operate while its management attempts to negotiate a resolution acceptable to all parties. The Company is a limited partner in the Grove and is not a guarantor of any debt related to the Grove.  The investment is held in a taxable REIT subsidiary where the Company has a $1,315,000 deferred tax liability related to the Grove.  The deferred tax liability represents taxable losses not yet recorded pursuant to the Equity Method of Accounting.

Critical Accounting Policies

Management’s discussion and analysis of financial condition and results of operations is based upon our condensed consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America, or GAAP.  The condensed consolidated financial statements of the Company include accounts of the Company and all majority-owned and controlled subsidiaries.  The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions in certain circumstances that affect amounts reported in the Company's condensed consolidated financial statements and related notes.  In preparing these financial statements, management has utilized information available including its past history, industry standards and the current economic environment, among other factors, in forming its estimates and judgments of certain amounts included in the condensed consolidated financial statements, giving due consideration to materiality.   On a regular basis, we evaluate our assumptions, judgments and estimates.    However, application of the critical accounting policies below involves the exercise of judgment and use of assumptions as to future uncertainties and, as a result, actual results could differ from these estimates.  In addition, other companies may utilize different estimates, which may impact comparability of the Company's results of operations to those of companies in similar businesses.  We believe there have been no material changes to the items that we disclosed as our critical accounting policies under Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our annual report.
 
 
Seq. Page 16

 

Revenue Recognition

Rental revenue is recognized on a straight-line basis, which averages minimum rents over the terms of the leases.  The excess of rents recognized over amounts contractually due, if any, is included in deferred rents receivable on the Company's balance sheet.  Alternatively, rents received in advance of rents recognized, if any, are included in deferred rent liability on the Company’s balance sheet. Certain leases also provide for tenant reimbursements of common area maintenance and other operating expenses and real estate taxes.  Tenant reimbursements to the Company for expenses where the Company negotiates, manages, contracts and pays the expense on behalf of the tenant are recognized as revenue when they become estimable and collectible. Ancillary and other property related income is recognized in the period earned.  The only exception to the straight line basis is for tenants at risk of default.  Revenue from tenants where collectability is in question is recognized on a cash basis when the rent is received.

Real Estate

Rental real estate assets, including land, buildings and improvements, furniture, fixtures and equipment are recorded at cost.  Tenant improvements, which are included in buildings and improvements, are also stated at cost.  Expenditures for ordinary maintenance and repairs are expensed to operations as they are incurred.  Renovations and/or replacements, which improve or extend the life of the asset, are capitalized and depreciated over their estimated useful lives.

Depreciation is computed utilizing the straight-line method over the estimated useful life of ten to thirty-nine years for buildings and improvements and three to twenty years for machinery and equipment.
 
The Company is required to make subjective assessments as to the useful life of its properties for purposes of determining the amount of depreciation to reflect on an annual basis with respect to those properties.  These assessments have a direct impact on the Company's net income.  Should the Company lengthen the expected useful life of a particular asset, it would be depreciated over more years, and result in less depreciation expense and increased annual net income.

Real estate held for development is stated at the lower of cost or net realizable value.  In addition to land, land development and construction costs, real estate held for development includes interest, real estate taxes and related development and construction overhead costs which are capitalized during the development and construction period. Net realizable value represents estimates, based on management’s present plans and intentions, of sale price less development and disposition cost, assuming that disposition occurs in the normal course of business.

Long Lived Assets

On a periodic basis, management assesses whether there are any indicators that the value of the real estate properties may be impaired. A property's value is considered to be impaired if management's estimate of the aggregate future cash flows (undiscounted and without interest charges) to be generated by the property is less than the carrying value of the property.  Such future cash flow estimates consider factors such as expected future operating income, trends and prospects, as well as the effects of demand, competition and other factors.  To the extent impairment occurs, the loss will be measured as the excess of the carrying amount of the property over the fair value of the property.

The Company is required to make subjective assessments as to whether there are impairments in the value of its real estate properties and other investments.  These assessments have a direct impact on the Company's net income, since an impairment charge results in an immediate negative adjustment to net income.  In determining impairment, if any, the Company has adopted Accounting for the Impairment or Disposal of Long Lived Assets.

Assets and Liabilities Measured at Fair-Value

On January 1, 2008, the Company adopted Fair Value Measurements, which defines fair value, establishes a framework for measuring fair value, and expands disclosures about fair-value measurements. The guidance for Fair Value Measurements applies to reported balances that are required or permitted to be measured at fair value under existing accounting pronouncements; accordingly, the standard does not require any new fair value measurements of reported balances.

 
 
Seq. Page 17

 
 
On January 1, 2008, the Company adopted The Fair Value Option for Financial Assets and Financial Liabilities, which permits companies to choose to measure certain financial instruments and other items at fair value in order to mitigate volatility in reported earnings caused by measuring related assets and liabilities differently. However, the Company has not elected to measure any additional financial instruments and other items at fair value (other than those previously required under other GAAP rules or standards) under the provisions of this standard.
 
The guidance for the Fair Value Option for Financial Assets and Financial Liabilities emphasizes that fair value is a market-based measurement, not an entity-specific measurement. Therefore, a fair-value measurement should be determined based on the assumptions that market participants would use in pricing the asset or liability. As a basis for considering market participant assumptions in fair-value measurements, the guidance establishes a fair-value hierarchy that distinguishes between market participant assumptions based on market data obtained from sources independent of the reporting entity (observable inputs that are classified within Levels 1 and 2 of the hierarchy) and the reporting entity’s own assumptions about market participant assumptions (unobservable inputs classified within Level 3 of the hierarchy).
 
Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company has the ability to access. Level 2 inputs are inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. Level 2 inputs may include quoted prices for similar assets and liabilities in active markets, as well as inputs that are observable for the asset or liability (other than quoted prices), such as interest rates, foreign exchange rates, and yield curves that are observable at commonly quoted intervals. Level 3 inputs are unobservable inputs for the asset or liability, which are typically based on an entity’s own assumptions, as there is little, if any, related market activity. In instances where the determination of the fair-value measurement is based on inputs from different levels of the fair-value hierarchy, the level in the fair-value hierarchy within which the entire fair-value measurement falls is based on the lowest level input that is significant to the fair-value measurement in its entirety. The Company’s assessment of the significance of a particular input to the fair-value measurement in its entirety requires judgment, and considers factors specific to the asset or liability.

Recent Development

As disclosed by the Company in its Current Report on Form 8-K filed on July 30, 2012 with the Securities and Exchange Commission, the Company received written notice on July 25, 2012 of the retirement of Stephen V. Maroney from his positions as the Company’s President and Chief Executive Officer and as a director, effective August 16, 2012.  In the notice, Mr. Maroney indicated that his retirement was a personal decision, which he had delayed in order to oversee the management of the Company’s condemnation litigation.  In light of the Company’s successful resolution of its condemnation litigation, Mr. Maroney determined that he no longer had reason to postpone his plans to retire.  Mr. Maroney has served as President and Chief Executive Officer since 1999.  The Company’s Board of Directors has commenced a search for a new Chief Executive Officer, which the Board expects to complete as soon as possible.

RESULTS OF OPERATIONS

Three Months Ended June 30, 2012 compared with the Three Months Ended June 30, 2011.

Rental revenues are comprised solely of rental income and amounted to $1,101,161 and $1,206,799 for the three months ended June 30, 2012 and 2011, respectively, a decrease of $105,638 or 9%.  The Flowerfield Industrial Park, Cortlandt Manor Medical Center and Port Jefferson Professional Park all experienced a decrease in revenue; amounting to $9,504, $66,514, and $31,990, respectively, while the Fairfax Medical Center experienced an increase of $2,370.  The reduction in revenue at the Flowerfield Industrial Park was primarily related to one tenant who defaulted on the lease.  The tenant was evicted June 30, 2012 and the Company has a judgment in the amount of $136,000. Revenue from the judgment will not be recorded until received.  Approximately $26,000 of the decrease at the Cortlandt Manor Medical Center was related to a drop in occupancy compared to the prior period due to two terminations and the balance of the decrease was due to a net reduction in the rate per square foot on lease renewals.  The Port Jefferson Professional Park’s decrease was primarily related to one tenant who did not renew their lease in the fourth quarter of 2011.  The net increase at the Fairfax Medical Center was primarily related to higher average occupancy for the second quarter of 2012 compared to the second quarter of 2011, supplemented by contractual annual rent escalations.

Tenant reimbursements represent expenses negotiated, managed and incurred directly by the Company on behalf of or for the benefit of the tenants.  Tenant reimbursements were $143,763 and $154,195 for the three months ended June 30, 2012 and 2011, respectively, a decrease of $10,432 or approximately 7%.  The reduction in tenant reimbursements was primarily related to terminations.

Rental expenses for the three months ended June 30, 2012 and 2011 were $555,633 and $588,960, respectively, a decrease of $33,327 or 6%.  Approximately $42,000 of the decrease was due to the reduction in maintenance expenses, partially offset by an approximate $7,000 increase in insurance costs and an approximate $5,000 increase in real estate taxes.

General and administrative expenses for the three months ended June 30, 2012 and 2011 were $477,429 and $452,178, respectively, an increase of $25,251 or 6%.  The major contributing factor to the increase was an increase in compensation and benefits of approximately $16,000.  Approximately $9,000 of the compensation and benefit increase was a non-cash charge directly related to the Company’s pension plan. The remaining difference is primarily related to a rise in corporate governance expenses.
 
 
Seq. Page 18

 

Depreciation expense for the three months ended June 30, 2012 and 2011 was $223,323 and $204,205, respectively, an increase of $19,118 or 9%.  The increase is mainly attributable to the 2011 renovations in the developed property portfolio.

Interest income, not including condemnation related interest, was $28,932 and $72 for the three months ended June 30, 2012 and 2011, respectively.  The increase in interest income is mainly attributable to the purchase of mortgage-backed securities during February and March of 2012.

Interest expense for the three months ended June 30, 2012 and 2011 was $252,105 and $307,428, respectively, a decrease of $55,323 or 18%.  The decrease was attributable primarily to the expiration of the Swap on the Cortlandt Manor mortgage which locked in the rate at 5.66%.  Following the expiration of the Swap, the rate adjusted down to Libor plus 225 basis points or approximately 2.5%.  In addition, the Company renegotiated the rate on the Port Jefferson mortgage effective March 1, 2012, reducing the rate over the next 5 years from 6% to 5%.

The Company is reporting a net loss before Condemnation Proceeds and Provision for Income Taxes for the three months ended June 30, 2012, and 2011 of $234,634 and $191,705. primarily due to the impact of the items discussed above

The income (expense) from condemnation proceeds was $100,111,890 and $(53,024) for the three months ended June 30, 2012 and 2011, respectively, an increase of $100,164,914.  The Company successfully concluded its condemnation case during the second quarter resulting in an additional $98,685,000 for just compensation for the Property and reimbursement of condemnation costs of $1, 474,941.  The Company incurred approximately $48,050 and $53,024 in condemnation costs during the three months ended June 30, 2012, and 2011, respectively.

Interest income on condemnation proceeds of  $67,265,788 resulted from the Company’s successful conclusion of its condemnation case for just compensation. The interest was received in early July 2012.

The provision for income tax for the six months ended June 30, 2012 was $61,649,000.  There was no provision or benefit for income tax for the three months ended June 30, 2012 and 2011. (see Footnote #6)

The Company is reporting a net income (loss) of $105,494,044 and $(244,729) for the three months ended June 30, 2012 and 2011, respectively, primarily due to the impact of the items discussed above.

Six Months Ended June 30, 2012 compared with the Six Months Ended June 30, 2011.

Rental revenues are comprised solely of rental income and amounted to $2,288,428 and $2,466,979 for the six months ended June 30, 2012 and 2011, respectively, a decrease of $178,551 or 7%.  The Flowerfield Industrial Park, Cortlandt Manor Medical Center, Port Jefferson Professional Park and Fairfax Medical Center, all experienced a decrease in revenue; amounting to $32,314, $56,039, $69,241and $20,958, respectively.  The reduction in revenue at the Flowerfield Industrial Park was primarily related to one tenant who defaulted on the lease.  The tenant was evicted as of June 30, 2012 and the Company has a Judgment in the amount of $136,000. Revenue from the Judgment will not be recorded until received.  The reduction in revenue at the Cortlandt Manor Medical Center was primarily related to a drop in occupancy compared to the prior period due to two terminations.  The Port Jefferson Professional Park’s Center’s decrease was primarily related to one tenant who did not renew their lease in the fourth quarter of 2011.  The reduction in revenue at the Fairfax Medical Center was primarily related to one tenant exercising an early termination option during the first quarter of 2011.  The option included a fee of $22,000 which was equivalent to one year’s rent.

Tenant reimbursements represent expenses negotiated, managed and incurred directly by the Company on behalf of or for the benefit of the tenants.  Tenant reimbursements were $292,632 and $304,714 for the six months ended June 30, 2012 and 2011, respectively.  The reduction in tenant reimbursements was primarily related to terminations.

Rental expenses for the six months ended June 30, 2012 and 2011 were $1,150,182 and $1,214,409, respectively, a decrease of $64,227 or 5%.  The Company reduced maintenance expenses by approximately $40,000.  Additionally, approximately $22,000 of the decrease was due to the Company successfully reducing the real estate taxes for the Port Jefferson Medical Center which was partially offset by net escalating real estate taxes at the remaining properties of approximately $8,000.  The remaining difference is primarily related to a reduction in the lease commission amortization expenses as a result of a prior year write-off of commissions related to an early termination at the Fairfax Medical Center.   The Company successfully offset escalating insurance costs of approximately $13,000 with lower utility costs.
 
 
Seq. Page 19

 

General and administrative expenses for the six months ended June 30, 2012 and 2011 were $952,262 and $907,729, respectively, an increase of $44,533 or 5%.  The major contributing factor to the increase was an increase in compensation and benefits of approximately $42,000.  Approximately $18,000 of the compensation and benefit increase was a non-cash charge directly related to the Company’s pension plan.

Depreciation expense for the six months ended June 30, 2012 and 2011 was $447,756 and $408,810, respectively, an increase of $38,946 or 10%.  The increase is mainly attributable to the 2011 renovations in the developed property portfolio.

Interest income, not including condemnation related interest, was $41,778 and $144 for the six months ended June 30, 2012 and 2011, respectively.  The increase in interest income is mainly attributable to the purchase of mortgage-backed securities during February and March of 2012.

Interest expense for the six months ended June 30, 2012 and 2011 was $513,017 and $613,083, respectively, a decrease of $100,066 or 16%.  The decrease was attributable primarily to the expiration of the Swap on the Cortlandt Manor mortgage which locked in the rate at 5.66%.  Following the expiration of the Swap, the rate adjusted down to Libor plus 225 basis points or approximately 2.5%.  In addition, the Company renegotiated the rate on the Port Jefferson mortgage effective March 1, 2012, reducing the rate over the next 5 years from 6% to 5%.

The Company is reporting a net loss before Condemnation Proceeds and Provision for Income Taxes for the six months ended June 30, 2012, and 2011 of $440,379 and $372,194 primarily due to the impact of the items discussed above

The income (expense) from condemnation proceeds was $100,048,691 and $(221,690) for the six months ended June 30, 2012 and 2011, respectively, an increase of $100,270,381.  The Company successfully concluded its condemnation case during the second quarter resulting in an additional $98,685,000 for just compensation for the Property and reimbursement of condemnation costs of $1, 474,941.  The Company incurred approximately $111,249 and $221,690 in condemnation costs during the six months ended June 30, 2012, and 2011, respectively.

Interest income on condemnation proceeds of $67,265,788 resulted from the Company’s successful conclusion of its condemnation case for just compensation. The interest was received in early July 2012.

The provision for income tax for the six months ended June 30, 2012 was $61,649,000.  There was no provision or benefit for income tax for the six months ended June 30, 2011.  (see Footnote #6)

The Company is reporting a net income (loss) of $105,225,100 and $(593,884) for the six months ended June 30, 2012 and 2011, respectively, primarily due to the impact of the items discussed above.
 
LIQUIDITY AND CAPITAL RESOURCES

Cash Flows:  We believe that a main focus of management is to effectively manage our balance sheet through cash flow management of our tenant leases, maintaining or improving occupancy, and pursuing and recycling of capital.

We generally finance our operations and acquisitions through a combination of cash on hand and debt.

As of June 30, 2012, the Company had cash and cash equivalents, totaling approximately $4.3 million and investments in U.S. guaranteed mortgage-backed securities of approximately $5.2 million.  The Company anticipates that the combination of its current cash balance and cash flow from continuing operations will be adequate to fund business operations, the debt amortization of our long term mortgages over the next twelve months and expenses associated with creating one or more liquidity events in accordance with our strategic plan.  In addition to these ongoing requirements, the continued economic challenges for small businesses, including the lack of available credit to many of our tenant classes who are small businesses, and the uncertainty facing medical tenants brought about by the 2010 Federal health care reform legislation, could adversely affect our operating results.  To address these risks and challenges, during 2011 the Company filed a registration statement on Form S-3 with the Securities and Exchange Commission to register a number of shares of the Company’s common stock to be offered in a rights offering by the Company to its shareholders with gross proceeds (if all rights were exercised) of $9,210,000 or $10,210,000 if an over-allotment option was exercised.  The Company received subscriptions for approximately 294,685 shares, greatly exceeding the maximum shares offered of 173,305, and the Company elected to exercise its overallotment option to issue an additional 19,336 shares to satisfy over-subscription requests. Shareholders were allocated 100% of their basic subscriptions.  The rights offering resulted in 192,641 common shares being issued, and net proceeds (after expenses) raised of $9,961,476.
 
 
Seq. Page 20

 

As of June 30, 2012, approximately $5.2 million of the proceeds are invested in mortgage-backed securities with both AA and AAA ratings fully guaranteed by US government agencies (the Federal National Mortgage Association and the Federal Home Loan Mortgage Corporation), Net cash used in operating activities was $381,153 and $356,054 during the six months ended June 30, 2012 and 2011, respectively. The underlying factors that impact working capital and therefore cash flows from operations are the timing of collections of rents and related tenant reimbursements and the payment of operating and general and administrative expenses.   Additionally, the Company concluded its condemnation litigation in June 2012 resulting in the Company recording the condemnation receivable and related income of $167,425,279 inclusive of interest through June 30, 2012.  The state remitted payment of $167,501,657 in early July including additional interest up to date of payment.  The cash used in operating activities in the current period was primarily related to condemnation expenses incurred of  $111,250 and an increase in prepaid expenses of $197,687.  The cash used in operating activities in the prior period was primarily related to the reduction in accounts payable of $273,282 and an increase in prepaid expenses of $78,660.

Net cash used in investing activities was $5,392,447 and $550,294 during the six months ended June 30, 2012 and 2011, respectively. Cash used in investing activities in the current period was primarily attributable to the purchases of securities of approximately $5.2 million net of principal distributions.  The securities are currently generating a yield of approximately 2%.  Cash used in investing activities in the prior period was primarily due to property taxes on our undeveloped land and tenant improvements most of which was contracted for in 2010.

Net cash used in financing activities was $308,454 and $282,022 during the six months ended June 30, 2012 and 2011, respectively.  The cash used in financing activities in both respective periods was comprised of scheduled principal payments on the Company’s debt service obligations.

Beginning in the second half of 2007, the residential mortgage and capital markets began showing signs of stress, primarily in the form of escalating default rates on sub-prime mortgages, declining residential home values and increasing inventory nationwide. This credit crisis spread to the broader commercial credit markets and has reduced the availability of financing and increased interest rates.   The extended weak economy, unemployment and lack of liquidity combined with the impact of the Healthcare Legislation has resulted in an extensive reduction in occupancy rates and related rental rates across residential, commercial and medical office properties.  In certain cases the Company has addressed these challenges to date through various tenant incentives which resulted in the Company’s current market rents and related occupancy rates.

The economic climate continues to negatively impact the volume and pricing of real estate transactions.  Despite the fact that the Company has invested in medical office buildings, an asset class that has been less vulnerable, if these conditions continue, our portfolio may experience lower occupancy and effective rents, which would result in a corresponding decrease in net income, funds from operations and cash flows.   While the Company has been successful maintaining its effective rental rates, its revenue commitments have been decreasing which the Company attributes mainly to the challenges of renewing tenants into multi-year leases in the face of an economy that is volatile supplemented by the challenges of attracting new tenants.
 
LIMITED PARTNERSHIP INVESTMENT

The Company has a limited partnership investment in the “Grove”, which owns a 3,700+ acre citrus grove located in Palm Beach County, Florida, which is the subject of a plan for mixed-use development. The investment currently represents an estimated 9.32% interest in the Grove.  The Company is accounting for the investment under the equity method.  As of June 30, 2012, the carrying value of the Company’s investment was $0.  The Company cannot predict what, if any, value it will ultimately realize from this investment.

In November 2010, the Grove made an offering to its partners to invest additional funds in the partnership.  The offering, had a minimum and maximum aggregate offering amount of $2 million and $3 million, respectively, and was due to expire on December 10, 2010. In November 2010, after careful deliberation, the Company informed the Grove that it would not participate in the offering. Subsequently, the Company was informed that the offering would remain open until March 10, 2011. The Company’s non-participation in the offering was expected to dilute its ownership interest to 8.98% from 9.99%, depending on the amount raised in the offering.  The Grove completed its offering which closed on March 10, 2011 with a capital raise of $2 million.  The Company has not yet received the dilution impact or any other details following the close of the offering but estimates its new ownership interest will be reduced from 9.99% to 9.32%.

On March 18, 2011, the Grove’s lender, Prudential Industrial Properties, LLC (“Prudential”), commenced a foreclosure action against the Grove by filing a complaint in the Circuit Court of Palm Beach County to foreclose upon the Grove property, alleging that the Grove has defaulted on its loan from Prudential and that the Grove is indebted to Prudential in the amount of over $37 million in principal and over $8 million in interest and fees.  The Company is a limited partner in the Grove, and is not a guarantor of any debt related to the Grove.  The investment is held in a taxable REIT subsidiary where the Company has a $1,315,000 deferred tax liability related to the Grove.  The deferred tax liability represents taxable losses not yet recorded pursuant to the Equity Method of Accounting.
 
 
Seq. Page 21

 
 
OFF-BALANCE SHEET ARRANGEMENTS

The Company has no off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on its financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

Not required for smaller reporting companies.

Item 4. Controls and Procedures.

The Company’s management, including the Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), have evaluated the effectiveness of the Company’s disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) as of June 30, 2012. Based upon that evaluation, the Company’s CEO and CFO concluded that the disclosure controls and procedures were effective, in all material respects, to ensure that information required to be disclosed in the reports the Company files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission and that information is accumulated and communicated to the Company’s management, including the CEO and CFO, to allow timely decisions regarding required disclosure. It should be noted that design of any system of controls is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions regardless of how remote.

There have been no changes in the Company’s internal control over financial reporting identified in connection with the evaluation required by paragraph (d) of Exchange Act Rule 13a-15 that occurred during the Company’s last fiscal quarter that has materially affected, or that is reasonably likely to materially affect, the Company’s internal control over financial reporting.

PART II - OTHER INFORMATION

 
Item 1. Legal Proceedings
 
Gyrodyne Company of America, Inc. v. The State of New York

On July 3, 2012, the Company received $167,501,656.95 from the State of New York (the “State”) in payment of the judgments in the Company’s favor in the condemnation litigation with the State.  The amount received consisted of $98,685,000 in additional damages, $1,474,940.67 in costs, disbursements and expenses, and $67,341,716.28 in interest.

The $167.5 million payment brings to a successful resolution the Company’s case for just compensation, commenced in 2006 for the 245.5 acres of its Flowerfield property in St. James and Stony Brook, New York (the “Property”) taken by the State.  The State had paid the Company $26,315,000 for the Property in March 2006, which the Company elected, under New York’s eminent domain law, to treat as an advance payment while it pursued its claim for just compensation.  The Court of Claims ruled in the Company’s favor in June 2010 when it awarded the Company $125,000,000, thereby requiring the State to pay an additional $98,685,000 plus statutory interest of nine percent from the date of taking on November 2, 2005 to the date of payment.  That Judgment, as well as a related Judgment for costs, disbursements and expenses, was affirmed by the Appellate Division and the Court of Appeals.

The Company recorded income of $167,425,729 including interest through June 30, 2012 in the quarter ended June 30, 2012 and will record the balance of the interest earned through July 3, 2012 of $104,928 in the financial statements for the third quarter ending September 30, 2012.

In addition, in the normal course of business, the Company is a party to various legal proceedings.  After reviewing all actions and proceedings pending against or involving the Company, management considers the aggregate loss, if any, will not be material to the Company’s financial statements.

Items 1A through 5 are not applicable to the six months ended June 30, 2012.

 
Seq. Page 22

 
 
Item 6. Exhibits.
 
 
3.1
Restated Certificate of Incorporation of Gyrodyne Company of America, Inc. (1)

 
3.2 
Amended and Restated Bylaws of Gyrodyne Company of America, Inc. (2)
 
 
4.1
Form of Stock Certificate of Gyrodyne Company of America, Inc. (3)

 
4.2
Rights Agreement, dated as of August 10, 2004, by and between Gyrodyne Company of America, Inc. and Registrar and Transfer Company, as Rights Agent, including as Exhibit B the forms of Rights Certificate and of Election to Purchase. (4)

 
31.1 
Rule 13a-14(a)/15d-14(a) Certification of Chief Executive Officer. (5)

 
31.2 
Rule 13a-14(a)/15d-14(a) Certification of Chief Financial Officer. (5)

 
32.1
CEO Certification Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. (5)

 
32.2
CFO Certification Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. (5)
 
101.INS**XBRL Instance

101.SCH**XBRLTaxonomy Extension Schema

101.CAL**XBRL Taxonomy Extension Calculation

101.DEF**XBRL Taxonomy Extension Definition

101.LAB**XBRL Taxonomy Extension Labels

101.PRE**XBRL Taxonomy Extension Presentation

 
(1)
Incorporated herein by reference to the Annual Report on Form 10-KSB/A, filed with the Securities and Exchange Commission on September 5, 2001.

 
(2) 
Incorporated herein by reference to Form 8-K, filed with the Securities and Exchange Commission on June 18,2008.

 
(3) 
Incorporated herein by reference to the Quarterly Report on Form 10-Q, filed with the Securities and ExchangeCommission on November 13, 2008.

 
(4) 
Incorporated herein by reference to Form 8-K, filed with the Securities and Exchange Commission on August 13, 2004.
 
 
(5)
Filed as part of this report.
 
** XBRL information is furnished and not filed or a part of a registration statement or prospectus for purposes of sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections.
 
 
Seq. Page 23

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

GYRODYNE COMPANY OF AMERICA, INC.




Date: August 13, 2012
 
/s/ Stephen V. Maroney
 
   
By Stephen V. Maroney
 
   
President and Chief Executive Officer
 
 
 
 
Date: August 13, 2012
 
/s/ Gary Fitlin
 
   
By Gary Fitlin
 
   
Chief Financial Officer and Treasurer
 
 
 
Seq. Page 24

 
 
EXHIBIT INDEX
 
 
3.1
Restated Certificate of Incorporation of Gyrodyne Company of America, Inc. (1)

 
3.2 
Amended and Restated Bylaws of Gyrodyne Company of America, Inc. (2)
 
 
4.1
Form of Stock Certificate of Gyrodyne Company of America, Inc. (3)

 
4.2
Rights Agreement, dated as of August 10, 2004, by and between Gyrodyne Company of America, Inc. and Registrar and Transfer Company, as Rights Agent, including as Exhibit B the forms of Rights Certificate and of Election to Purchase. (4)

 
31.1 
Rule 13a-14(a)/15d-14(a) Certification of Chief Executive Officer. (5)

 
31.2 
Rule 13a-14(a)/15d-14(a) Certification of Chief Financial Officer. (5)

 
32.1
CEO Certification Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. (5)

 
32.2
CFO Certification Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. (5)
 
101.INS**XBRL Instance

101.SCH**XBRLTaxonomy Extension Schema

101.CAL**XBRL Taxonomy Extension Calculation

101.DEF**XBRL Taxonomy Extension Definition

101.LAB**XBRL Taxonomy Extension Labels

101.PRE**XBRL Taxonomy Extension Presentation

 
(1)
Incorporated herein by reference to the Annual Report on Form 10-KSB/A, filed with the Securities and Exchange Commission on September 5, 2001.

 
(2) 
Incorporated herein by reference to Form 8-K, filed with the Securities and Exchange Commission on June 18,2008.

 
(3) 
Incorporated herein by reference to the Quarterly Report on Form 10-Q, filed with the Securities and ExchangeCommission on November 13, 2008.

 
(4) 
Incorporated herein by reference to Form 8-K, filed with the Securities and Exchange Commission on August 13, 2004.
 
 
(5)
Filed as part of this report.
 
** XBRL information is furnished and not filed or a part of a registration statement or prospectus for purposes of sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections.
 
 
Seq. Page 25

XNAS:GYRO Gyrodyne Company of America Quarterly Report 10-Q Filling

Gyrodyne Company of America XNAS:GYRO Stock - Get Quarterly Report SEC Filing of Gyrodyne Company of America XNAS:GYRO stocks, including company profile, shares outstanding, strategy, business segments, operations, officers, consolidated financial statements, financial notes and ownership information.

XNAS:GYRO Gyrodyne Company of America Quarterly Report 10-Q Filing - 6/30/2012
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Title |  Date |  Company |  Symbol |  Interest |  Popularity

Previous: XNAS:GYRO Gyrodyne Company of America Quarterly Report 10-Q Filing - 3/31/2012  |  Next: XNAS:HAFC Hanmi Financial Corp Insider Activity 4 Filing - 2/21/2012